StriVectin
Advanced Retinol Nightly Renewal Moisturizer - 1.7 oz
Moisturizer – for Fine lines & wrinkles
$119.0050.3ml · $2.37/ml
Ideal for
- ExcellentFine lines & wrinkles
- ExcellentDryness
- StrongDark spots & hyperpigmentation
- StrongUneven tone & radiance
Not recommended for
StriVectin
Advanced Retinol Nightly Renewal Moisturizer - 1.7 oz
Moisturizer – for Fine lines & wrinkles
$119.0050.3ml · $2.37/ml
Ideal for
- ExcellentFine lines & wrinkles
- ExcellentDryness
- StrongDark spots & hyperpigmentation
- StrongUneven tone & radiance
Not recommended for
Product Score
Breakdown of key factors contributing to this product match
Research Score
62%
100 scientific studies support the efficacy of this product's ingredients. 100% is the strongest evidence we typically find in a retinoid treatment for concerns like yours.
Consumer Reviews
88%
Based on 384 customer reviews (4.6★). Positive feedback from users with similar skin profiles and concerns.
Targets Your Concerns
Product Ingredients (28)
Network meta-analysis of 23 RCTs (n=3,905) of topical interventions for facial photoaging: isotretinoin, retinol and tretinoin significantly improved fine wrinkles (isotretinoin ranked highest); tazarotene was most effective for coarse wrinkles and glycolic acid for roughness; tretinoin and retinol were superior for hyperpigmentation, with tretinoin showing the most favorable safety profile.
Meta-analysis of 8 RCTs (n=1,361) of topical tretinoin, the active retinoid to which retinol is metabolized in skin, for photodamaged facial skin: tretinoin significantly improved fine wrinkles (mean difference 0.41) and coarse wrinkles (MD 0.25) versus control, with more frequent skin irritation (OR 3.14).
Comprehensive review of moisturization mechanisms: glycerin contributes to corneocyte hydration by replacing lost natural moisturizing factor (NMF) components; maintains stratum corneum fluidity at low humidity; superior humectant performance vs propylene glycol, sorbitol, and urea in controlled comparisons
Review of how moisturizers affect the epidermal barrier: humectants such as glycerin increase stratum corneum hydration and can strengthen barrier function and resistance to irritation, although effects depend on formulation and some moisturizers may weaken the barrier; supports well-formulated glycerin-containing emollients for dry, barrier-impaired skin.
Review establishing glycerin as the gold standard humectant: attracts water to stratum corneum via hydrogen bonding, improves skin mechanical properties (elasticity, pliability), enhances desmosome degradation for smooth desquamation, and modulates aquaporin-3 channels; effective at 2-20% in topical formulations
Review confirms dermal HA declines ~50% by age 70; topical HA penetration is MW-dependent (fragments <50 kDa penetrate deeper but may paradoxically stimulate inflammation); multi-weight formulations balance hydration and penetration depth
Systematic review of topical vitamin C for melasma and photoaging: concludes topical ascorbic acid improves photoaging signs (fine lines, roughness, pigmentation) and contributes to melasma lightening, supporting its use as an antioxidant/depigmenting agent, while formulation instability/oxidation and study heterogeneity limit firm conclusions.
Topical retinol (vitamin A) applied to naturally aged, sun-protected human skin antagonized the age-related decline in fibroblast growth and the elevated collagen-degrading matrix metalloproteinases, and stimulated new collagen synthesis, supporting retinol's ability to reverse molecular markers of dermal aging.
Double-blind, vehicle-controlled, 6-month trial: 5% vitamin C cream significantly improved clinical photoaging score; punch biopsies confirmed increased type I and type III collagen mRNA and protein, plus decreased MMP-1; one of the few biopsy-proven vitamin C studies
Placebo-controlled, double-blind RCT (n=24, atopic dermatitis): a glycerol-based emollient applied twice daily for 4 weeks significantly improved stratum corneum hydration and restored epidermal barrier function versus a glycerol-free placebo; no significant differences from placebo were found for erythema, SCORAD, or local severity scores.















